📗 Cite This Artifact
IGHMBP2 Gene
IGHMBP2 Gene
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">IGHMBP2 Gene</th>
</tr>
<tr>
<td class="label">Model</td>
<td>Applications</td>
</tr>
<tr>
<td class="label">Mouse models</td>
<td>Phenotype studies</td>
</tr>
<tr>
<td class="label">Zebrafish</td>
<td>Developmental studies</td>
</tr>
<tr>
<td class="label">Patient iPSCs</td>
<td>Disease mechanism, drug screening</td>
</tr>
<tr>
<td class="label">Drosophila</td>
<td>Genetic interactions</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Ighmbp2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
IGHMBP2 (Immunoglobulin Mu Binding Protein 2, also known as SMUBP-2 or DNA helicase-related protein) is a gene located on chromosome 11p15.5 that encodes a DNA/RNA helicase with critical roles in neuronal development, RNA processing, and transcriptional regulation.[@grohmann2001][@kenna2016] Mutations in IGHMBP2 cause a spectrum of neuromuscular disorders including spinal muscular atrophy with respiratory distress (SMARD1), classic amyotrophic lateral sclerosis (ALS), and Charcot-Marie-Tooth disease type 2A (CMT2A).[@guerrero2018][@l2019]
IGHMBP2 Gene
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">IGHMBP2 Gene</th>
</tr>
<tr>
<td class="label">Model</td>
<td>Applications</td>
</tr>
<tr>
<td class="label">Mouse models</td>
<td>Phenotype studies</td>
</tr>
<tr>
<td class="label">Zebrafish</td>
<td>Developmental studies</td>
</tr>
<tr>
<td class="label">Patient iPSCs</td>
<td>Disease mechanism, drug screening</td>
</tr>
<tr>
<td class="label">Drosophila</td>
<td>Genetic interactions</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Ighmbp2 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
IGHMBP2 (Immunoglobulin Mu Binding Protein 2, also known as SMUBP-2 or DNA helicase-related protein) is a gene located on chromosome 11p15.5 that encodes a DNA/RNA helicase with critical roles in neuronal development, RNA processing, and transcriptional regulation.[@grohmann2001][@kenna2016] Mutations in IGHMBP2 cause a spectrum of neuromuscular disorders including spinal muscular atrophy with respiratory distress (SMARD1), classic amyotrophic lateral sclerosis (ALS), and Charcot-Marie-Tooth disease type 2A (CMT2A).[@guerrero2018][@l2019]
The IGHMBP2 gene (NCBI Gene ID: 3608, Ensembl: ENSG00000140950, OMIM: 602575, UniProt: Q9UHK6) encodes a protein of 993 amino acids with ATP-dependent DNA and RNA helicase activity.[@grohmann2001] The protein is expressed throughout the nervous system with particularly high expression in motor [neurons](/entities/neurons), the spinal cord, and brainstem.
Gene Structure and Expression
Genomic Organization
The IGHMBP2 gene spans approximately 27 kb of genomic DNA on chromosome 11p15.5. The gene contains 13 exons that encode the 993-amino acid protein (approximately 110 kDa).[@grohmann2001]
The gene promoter contains multiple neuronal regulatory elements including binding sites for:
- REST (RE1-silencing transcription factor)
- Neuronalrestrictive silencer element (NRSE)
- Various homeobox transcription factors
Tissue Distribution
IGHMBP2 shows highest expression in:
- Motor neurons: Spinal cord anterior horn cells, brainstem motor nuclei
- Central nervous system: [Cortex](/brain-regions/cortex), [hippocampus](/brain-regions/hippocampus), cerebellum
- Peripheral nervous system: Dorsal root ganglia, peripheral nerves
- Cardiac and skeletal muscle: Lower expression
The motor neuron enrichment explains the predominant motor phenotype in IGHMBP2-related diseases.[@allen]
Protein Structure and Function
Molecular Architecture
IGHMBP2 contains several functional domains:
The protein functions as both a DNA helicase and an RNA helicase, with the ability to unwind nucleic acid duplexes in an ATP-dependent manner.[@grohmann2001]
Normal Cellular Functions
Transcriptional Regulation
IGHMBP2 regulates transcription of multiple neuronal genes, including:
- Genes involved in axonal guidance
- Synaptic protein genes
- Mitochondrial function genes
The protein can bind to specific DNA sequences and modulate gene expression through chromatin remodeling.[@chen2017]
RNA Processing
IGHMBP2 participates in:
- Pre-mRNA splicing
- RNA transport
- Translation regulation
The protein associates with RNA processing complexes and may regulate mRNA stability and localization in neurons.[@kenna2016]
Mitochondrial Function
IGHMBP2 localizes to mitochondria in neurons and regulates:
- Mitochondrial DNA replication
- Mitochondrial gene expression
- Mitochondrial dynamics
Loss of IGHMBP2 leads to mitochondrial dysfunction and energy deficits.[@wiedemann2020]
Axonal Development
During development, IGHMBP2 regulates:
- Axonal outgrowth
- Neuronal migration
- Synapse formation
The protein is transported along axons and localizes to growth cones.[@liu2018]
Disease Associations
Spinal Muscular Atrophy with Respiratory Distress (SMARD1)
SMARD1 (OMIM: 604320) is an autosomal recessive disorder caused by biallelic IGHMBP2 mutations. It presents in infancy with:
- Severe respiratory distress (diaphragmatic paralysis)
- Progressive muscular weakness
- Distal muscle atrophy (more pronounced than proximal)
- Autonomic dysfunction
- Normal intelligence
SMARD1 is distinguished from classic SMA by the early respiratory involvement and distal-predominant weakness.[@guerrero2018]
Amyotrophic Lateral Sclerosis (ALS)
Heterozygous IGHMBP2 missense mutations have been identified in families with adult-onset ALS.[@l2019] Features include:
- Progressive limb weakness and spasticity
- Bulbar involvement
- Cognitive involvement in some cases
- Typical ALS progression
The exact contribution of IGHMBP2 to ALS pathogenesis remains under investigation, with both loss-of-function and dominant-negative mechanisms proposed.[@l2019]
Charcot-Marie-Tooth Disease Type 2A (CMT2A)
Recessive IGHMBP2 mutations cause a CMT2A-like neuropathy phenotype with:[@fusco2021]
- Adult onset
- Sensorimotor neuropathy
- Distal weakness and atrophy
- Variable sensory involvement
Other Neurological Conditions
- Spinal muscular atrophy: Overlap with SMARD1 phenotype
- Neuromuscular junction disorders: Reported in some cases
- Cardiomyopathy: Rare cardiac involvement
Molecular Mechanisms of Neurodegeneration
Mitochondrial Dysfunction
IGHMBP2 deficiency leads to severe mitochondrial impairment:[@wiedemann2020]
- Reduced mitochondrial DNA copy number
- Impaired complex I activity
- Reduced ATP production
- Increased [reactive oxygen species](/entities/reactive-oxygen-species) (ROS)
Motor neurons are particularly vulnerable due to their high energy requirements and long axons.
RNA Processing Defects
Loss of IGHMBP2 disrupts:
- Normal splicing patterns
- mRNA transport
- Local translation at synapses
These defects impair axonal maintenance and synaptic function.[@kenna2016]
Transcriptional Dysregulation
IGHMBP2 mutations alter expression of:
- Mitochondrial genes
- Axonal guidance molecules
- Synaptic proteins
This leads to impaired neuronal connectivity and survival.[@chen2017]
Axonal Transport Defects
IGHMBP2 deficiency impairs:
- Mitochondrial transport
- Neurotrophin trafficking
- Synaptic vesicle transport
These defects contribute to distal axonopathy.[@liu2018]
Autophagy Impairment
Recent evidence suggests IGHMBP2 regulates autophagy, and loss of function leads to accumulation of autophagic vacuoles.[@zhang2022]
Genetic Landscape
Mutation Spectrum
Pathogenic IGHMBP2 variants include:
- Missense mutations: Predominantly in helicase domain (~40%)
- Nonsense/frameshift mutations: Truncated protein (~35%)
- Splice site mutations: Altered splicing (~20%)
- Large deletions: Less common (~5%)
Most pathogenic variants result in loss of helicase activity.[@guerrero2018]
Genotype-Phenotype Correlations
Some correlations exist:
- Biallelic truncating mutations: Severe SMARD1 phenotype
- Missense mutations (heterozygous): ALS or CMT2A
- Compound heterozygous: Variable severity
Carrier Frequency
Carrier frequency is approximately 1:350 in European populations.[@gnomad]
Diagnostic Testing
Genetic Testing
IGHMBP2 analysis is included in:
- SMA gene panels (differential diagnosis)
- ALS gene panels
- Hereditary neuropathy panels
- Whole exome sequencing
Biomarkers
Research biomarkers include:
- [Neurofilament light](/biomarkers/neurofilament-light-chain-nfl) chain (NfL): Elevated in serum/CSF[@liu2020]
- Mitochondrial function tests: Impaired in patient cells
- EMG findings: Neurogenic changes
Neurophysiology
- Nerve conduction studies: Reduced CMAP amplitudes
- EMG: Chronic neurogenic changes
- Respiratory function: Serial monitoring essential in SMARD1
Therapeutic Approaches
Current Management
No disease-modifying therapies exist. Management includes:
SMARD1
- Respiratory support (non-invasive ventilation)
- Nutritional support (feeding difficulties)
- Physical therapy
- Orthopedic care (contracture prevention)
- Cardiac monitoring
ALS/CMT2A
- Supportive care per standard protocols
- Riluzole (ALS)
- Physical/occupational therapy
- Assistive devices
Emerging Therapies
Gene Therapy
AAV-mediated gene delivery approaches are in development:
- Systemic delivery
- Intrathecal delivery
- Motor neuron targeting[@gene2023]
Small Molecule Approaches
Screening has identified:
- Mitochondrial protectants
- RNA splicing modulators
- [Autophagy](/entities/autophagy) enhancers
Antisense Oligonucleotides
ASO approaches to modulate splicing or enhance function are under investigation.[@aso2022]
Experimental Models
Research Directions
Key questions include:
Summary
IGHMBP2 encodes an ATP-dependent DNA/RNA helicase essential for motor neuron function. Biallelic loss-of-function mutations cause SMARD1, a severe infantile neuromuscular disorder with respiratory failure. Heterozygous missense mutations are associated with adult-onset ALS and CMT2A neuropathy. The disease mechanisms involve mitochondrial dysfunction, RNA processing defects, and transcriptional dysregulation. Understanding IGHMBP2 function provides insights into motor neuron biology and identifies potential therapeutic targets.
Background
The study of Ighmbp2 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
See Also
- [Neurodegeneration](/diseases/neurodegeneration)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
External Links
- [PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
- [NCBI Gene](https://www.ncbi.nlm.nih.gov/gene/) - Gene database
- [UniProt](https://www.uniprot.org/) - Protein database
References
▸Metadataorigin_type: v1_polymorphic_backfill
| slug | genes-ighmbp2 |
| kg_node_id | IGHMBP2 |
| entity_type | gene |
| origin_type | v1_polymorphic_backfill |
| source_table | wiki_pages |
| wiki_page_id | wp-1ba982cdc869 |
| __merged_from | {'merged_at': '2026-05-13', 'unprefixed_id': 'genes-ighmbp2'} |
| _schema_version | 1 |
No provenance edges found
Use ?embed=1 to load the artifact without SciDEX chrome — suitable for iframing into wiki pages or external sites.
<iframe src="http://scidex.ai/artifact/wiki-genes-ighmbp2?embed=1" width="100%" height="600" style="border:0;border-radius:8px"></iframe>
[IGHMBP2 Gene](http://scidex.ai/artifact/wiki-genes-ighmbp2)
http://scidex.ai/artifact/wiki-genes-ighmbp2